Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.39 is 31% below its 5-year average of 3.46, near the low end of its 5-year range (1.15–6.68).
As of the fiscal period ended Tuesday, June 30, 2026. 37.65% above its 12-month average of 1.74.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.39.
CURRENT RATIO
2.39
CURRENT RATIO AVG TTM
1.74
CURRENT RATIO AVG 3Y
2.90
CURRENT RATIO AVG 5Y
3.46
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+37.65%
CURRENT VS 3Y AVG
-17.41%
CURRENT VS 5Y AVG
-30.80%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.48
median of 699 covered companies
CURRENT VS SECTOR MEDIAN
-31.20%
vs the sector median at left
Market Cap
$83.04M
Current Ratio
7.99
TTM Avg
9.12
3Y Avg
12.06
5Y Avg
14.25
Market Cap
$85.01M
Current Ratio
1.98
TTM Avg
0.65
3Y Avg
1.44
5Y Avg
2.62
Market Cap
$85.01M
Current Ratio
7.85
TTM Avg
4.70
3Y Avg
2.98
5Y Avg
5.25
Market Cap
$85.01M
Current Ratio
7.03
TTM Avg
3.05
3Y Avg
3.90
5Y Avg
4.20
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LENSAR Inc (LNSR) | $82.41M | 2.39 | 1.74 | 2.90 | 3.46 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $83.04M | 7.99 | 9.12 | 12.06 | 14.25 |
| MediciNova, Inc. (MNOV)vs › | $83.18M | 8.75 | 11.02 | 14.04 | 18.21 |
| Nutriband Inc. (NTRB)vs › | $81.57M | 4.21 | 5.62 | 3.96 | 3.83 |
| Citius Oncology, Inc. (CTOR)vs › | $80.89M | 0.73 | 0.45 | 0.43 | 0.43 |
| Pulmonx Corporation (LUNG)vs › | $80.04M | 4.32 | 5.33 | 6.57 | 9.68 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $85.01M | 1.98 | 0.65 | 1.44 | 2.62 |
| ProMIS Neurosciences, Inc. (PMN)vs › | $85.01M | 7.85 | 4.70 | 2.98 | 5.25 |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.01M | 7.03 | 3.05 | 3.90 | 4.20 |
| Humacyte, Inc. (HUMA)vs › | $85.16M | 6.21 | 3.04 | 4.62 | 7.16 |
Current Ratio
2.39
Quick Ratio
1.13
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.39 |
| 2026-03-31 | 2.38 |
| 2025-12-31 | 1.15 |
| 2025-09-30 | 1.24 |
| 2025-06-30 | 1.52 |
| 2025-03-31 | 1.81 |
| 2024-12-31 | 2.80 |
| 2024-09-30 | 3.37 |
| 2024-06-30 | 3.88 |
| 2024-03-31 | 4.06 |
| 2023-12-31 | 3.99 |
| 2023-09-30 | 4.42 |
| 2023-06-30 | 4.66 |
| 2023-03-31 | 3.00 |
| 2022-12-31 | 2.95 |
| 2022-09-30 | 3.29 |
| 2022-06-30 | 3.14 |
| 2022-03-31 | 4.97 |
| 2021-12-31 | 5.14 |
| 2021-09-30 | 5.81 |
| 2021-06-30 | 6.68 |
| 2021-03-31 | 8.98 |
| 2020-12-31 | 6.90 |
| 2020-09-30 | 7.25 |
| 2020-06-30 | 3.36 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 2.19 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
